Osteo Bi-Flex Triple Strength + Vitamin D
Osteo Bi-Flex Triple Strength + Vitamin D is a joint and bone support supplement featuring a blend of ingredients. Each two-tablet serving provides 1500 mg of Glucosamine Hydrochloride, 100 mg of Joint Shield 5-Loxin Advanced, and 275 mg of a Chondroitin/MSM complex. It also includes 50 mcg (2000 IU) of Vitamin D, which is noted as underdosed compared to some clinical recommendations for bone health. The product received an N+ Score of 59, earning an 'F' grade, placing it in the average tier. While label transparency is high, the ingredient adequacy score is low, indicating that key ingredients may not be at optimal levels for their intended purpose. This product is designed for adults interested in supporting joint comfort and bone health.
About This Product
Osteo Bi-Flex Triple Strength + Vitamin D by Osteo Bi-Flex is a joint & bone supplement containing 7 active ingredients. It has earned an N+ Score of 59/100 (Grade F).
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Comprehensive formula with expected ingredients for its category
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
Weaknesses
- −Several ingredients below clinically effective doses
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 10.000 Calorie(s) | N/A |
| Vitamin D | 50.000 mcg | Under |
| Total Carbohydrates | 2.000 Gram(s) | N/A |
| Sodium | 20.000 mg | N/A |
| Glucosamine Hydrochloride | 1500.000 mg | N/A |
| Chondroitin/MSM complex | 275.000 mg | N/A |
| Joint Shield 5-Loxin Advanced | 100.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.